Working… Menu

Study of Erlotinib With or Without Investigational Drug (U3-1287) in Subjects With Advanced Non-small Cell Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01211483
Recruitment Status : Completed
First Posted : September 29, 2010
Last Update Posted : November 20, 2017
Information provided by (Responsible Party):
Daiichi Sankyo, Inc.

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Completed
Actual Primary Completion Date : October 2013
Actual Study Completion Date : November 23, 2013
Certification/Extension First Submitted : October 22, 2015
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 November 4, 2020
December 1, 2020
2 December 8, 2020
December 31, 2020